Extracorporeal Shock Wave Therapy (ESWT) is a non-invasive treatment used to address various musculoskeletal conditions, particularly chronic pain and injuries involving tendons and soft tissues. ESWT utilises high-energy acoustic waves to stimulate healing in targeted areas, making it an effective option for conditions such as plantar fasciitis and Achilles tendonitis.
The therapy works by delivering focused or radial shockwaves to the affected area. These shockwaves increase blood flow, stimulate cell metabolism, and promote the natural healing process by encouraging the regeneration of tissues. Additionally, ESWT breaks down calcifications and adhesions while reducing inflammation, leading to pain relief and improved function over time. It also desensitises pain receptors, offering immediate relief in some cases.
Treatment sessions are typically brief, lasting 10 to 20 minutes, with minimal discomfort during the procedure. Most patients require 3 to 5 sessions, spaced one week apart, to achieve optimal results. One of the key benefits of ESWT is its non-invasive nature, eliminating the need for surgery or extended recovery times. It is particularly suitable for patients who have not responded to other conservative treatments, such as physical therapy, medications, or orthotics.
ESWT is considered extremely safe, with few side effects, which may include mild swelling, or temporary discomfort in the treated area.
However, it is not recommended for individuals with certain medical conditions, such as blood clotting disorders, infections, or active malignancies.
By stimulating the body’s natural healing mechanisms, ESWT provides a long-lasting solution for chronic pain and soft tissue injuries. It offers a convenient and effective alternative for patients seeking non-surgical options to restore mobility, reduce pain, and improve quality of life. With growing clinical evidence supporting its efficacy, ESWT continues to be an increasingly popular treatment in podiatry and sports medicine.
